| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0075 | 1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |